{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:52:00Z","timestamp":1790117520631,"version":"4.0.1"},"reference-count":79,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,9,6]]},"DOI":"10.3233\/jad-160284","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T10:25:32Z","timestamp":1470133532000},"page":"445-456","source":"Crossref","is-referenced-by-count":56,"title":["Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"54","author":[{"given":"Eric L.","family":"Goldwaser","sequence":"first","affiliation":[{"name":"Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA"},{"name":"Graduate School of Biomedical Sciences, Rowan University, Stratford, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish K.","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirup","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA"},{"name":"Graduate School of Biomedical Sciences, Rowan University, Stratford, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Godsey","sequence":"additional","affiliation":[{"name":"Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA"},{"name":"Graduate School of Biomedical Sciences, Rowan University, Stratford, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Nagele","sequence":"additional","affiliation":[{"name":"Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA"},{"name":"Department of Geriatrics and Gerontology, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160284_ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160284_ref2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: The Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-160284_ref3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: The rotterdam study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-160284_ref4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: A population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-160284_ref5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2010-100012","article-title":"Type 2 diabetes mellitus, dyslipidemia, and Alzheimer\u2019s disease","volume":"20","author":"Carlsson","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/db08-0586","article-title":"Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.3233\/JAD-160284_ref7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/db06-0879","article-title":"The effect of borderline diabetes on the risk of dementia and Alzheimer\u2019s disease","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"key":"10.3233\/JAD-160284_ref8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00125-009-1323-x","article-title":"Uncontrolled diabetes increases the risk of Alzheimer\u2019s disease: A population-based cohort study","volume":"52","author":"Xu","year":"2009","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-160284_ref9","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"},{"key":"10.3233\/JAD-160284_ref10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/JAD-2009-0975","article-title":"Vascular factors in diabetes and Alzheimer\u2019s disease","volume":"16","author":"Taguchi","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.3233\/JAD-160284_ref12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch Neurol"},{"issue":"(Suppl 2)","key":"10.3233\/JAD-160284_ref13","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1753-4887.2010.00352.x","article-title":"Vascular basis for brain degeneration: Faltering controls and risk factors for dementia","volume":"68","author":"Kalaria","year":"2010","journal-title":"Nutr Rev"},{"key":"10.3233\/JAD-160284_ref14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-160284_ref15","doi-asserted-by":"crossref","first-page":"184042","DOI":"10.1155\/2012\/184042","article-title":"Dyslipidemia and blood-brain barrier integrity in Alzheimer\u2019s disease","volume":"2012","author":"Bowman","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"key":"10.3233\/JAD-160284_ref16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2174\/138161208784705441","article-title":"Diabetes, cognitive function, and the blood-brain barrier","volume":"14","author":"Huber","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-160284_ref17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00125-003-1235-0","article-title":"Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI","volume":"46","author":"den Heijer","year":"2003","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-160284_ref18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-160284_ref19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10654-011-9624-z","article-title":"The rotterdam scan study: Design and update up to 2012","volume":"26","author":"Ikram","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.3233\/JAD-160284_ref20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood-brain barrier permeability in Alzheimer\u2019s disease: A case-control MRI study","volume":"171","author":"Starr","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-160284_ref21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160284_ref22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.3233\/JAD-160284_ref23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160284_ref24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.3233\/JAD-160284_ref25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Suit","year":"2014","journal-title":"Peptides"},{"key":"10.3233\/JAD-160284_ref26","doi-asserted-by":"crossref","first-page":"708306","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: The missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-160284_ref27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/NEN.0b013e31826809a6","article-title":"IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood-brain barrier disruption","volume":"71","author":"Michalak","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-160284_ref28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-160284_ref29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-160284_ref30","doi-asserted-by":"crossref","first-page":"H2660","DOI":"10.1152\/ajpheart.00489.2006","article-title":"Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats","volume":"291","author":"Huber","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.3233\/JAD-160284_ref31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","article-title":"Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: Contribution of hyperglycaemia and matrix metalloproteinases","volume":"50","author":"Hawkins","year":"2007","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-160284_ref32","doi-asserted-by":"crossref","first-page":"681385","DOI":"10.1155\/2011\/681385","article-title":"Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer\u2019s disease, and epilepsy","volume":"2011","author":"Mizoguchi","year":"2011","journal-title":"Biochem Res Int"},{"key":"10.3233\/JAD-160284_ref33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.9758\/cpn.2013.11.2.45","article-title":"Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures","volume":"11","author":"Mizoguchi","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.3233\/JAD-160284_ref34","first-page":"908636","article-title":"Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-160284_ref35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2011-101959","article-title":"Blood-cerebrospinal fluid barrier permeability in Alzheimer\u2019s disease","volume":"25","author":"Chalbot","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(83)90157-0","article-title":"Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia","volume":"60","author":"Alafuzoff","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160284_ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-510X(85)90189-3","article-title":"CSF in Alzheimer\u2019s disease. Studies on blood-brain barrier function and intrathecal protein synthesis","volume":"70","author":"Elovaara","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160284_ref38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00002093-199706000-00004","article-title":"Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: Indication for disease subsets","volume":"11","author":"Hampel","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-160284_ref39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2169\/internalmedicine.37.509","article-title":"Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio","volume":"37","author":"Wada","year":"1998","journal-title":"Intern Med"},{"key":"10.3233\/JAD-160284_ref40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A population study on blood-brain barrier function in 85-year-olds: Relation to Alzheimer\u2019s disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-160284_ref41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1982.tb26848.x","article-title":"Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT)","volume":"396","author":"Wisniewski","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160284_ref42","first-page":"307","article-title":"The significance of small cerebral bleeds in neurodegenerative dementia syndromes","volume":"3","author":"De Reuck","year":"2012","journal-title":"Aging Dis"},{"key":"10.3233\/JAD-160284_ref43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brainres.2007.01.070","article-title":"Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons","volume":"1142","author":"Clifford","year":"2007","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160284_ref44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3233\/JAD-2011-110098","article-title":"Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-beta(1-42) deposition","volume":"25","author":"Nagele","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref45","first-page":"253","article-title":"Cerebral amyloid angiopathy and dementia","volume":"46","author":"Tian","year":"2004","journal-title":"Panminerva Med"},{"key":"10.3233\/JAD-160284_ref46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2008.07.092","article-title":"Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy","volume":"1234","author":"Clifford","year":"2008","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160284_ref47","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","article-title":"Blood-brain barrier impairment in Alzheimer disease: Stability and functional significance","volume":"68","author":"Bowman","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-160284_ref48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF00693782","article-title":"Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study","volume":"73","author":"Alafuzoff","year":"1987","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160284_ref49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(88)80085-X","article-title":"Lack of evidence for dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: An immunohistochemical study","volume":"9","author":"Rozemuller","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160284_ref50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1997.tb48469.x","article-title":"Serum protein leakage in Alzheimer\u2019s disease revisited","volume":"826","author":"Munoz","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160284_ref51","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.STR.27.11.2069","article-title":"Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer\u2019s disease patients","volume":"27","author":"Tomimoto","year":"1996","journal-title":"Stroke"},{"key":"10.3233\/JAD-160284_ref52","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160284_ref53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood-brain barrier","volume":"32","author":"Rosenberg","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160284_ref54","first-page":"138","article-title":"Blood-brain barrier permeability in aging and Alzheimer\u2019s disease","volume":"1","author":"Rosenberg","year":"2014","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.3233\/JAD-160284_ref56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-160284_ref57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of widespread BBB disruption in Alzheimer\u2019s disease models: Focus on therapeutic antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"key":"10.3233\/JAD-160284_ref58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s004410050944","article-title":"Glial cell extracellular matrix: Boundaries for axon growth in development and regeneration","volume":"290","author":"Fitch","year":"1997","journal-title":"Cell Tissue Res"},{"key":"10.3233\/JAD-160284_ref59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-122254","article-title":"Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: Beneficial effects of the LpPLA2 inhibitor darapladib","volume":"35","author":"Acharya","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2741\/e368","article-title":"Peripheral cholesterol, metabolic disorders and Alzheimer\u2019s disease","volume":"4","author":"Ledesma","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.3233\/JAD-160284_ref61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3233\/JAD-2009-1022","article-title":"Adiposity, type 2 diabetes, and Alzheimer\u2019s disease","volume":"16","author":"Luchsinger","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/diacare.14.5.366","article-title":"Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population","volume":"14","author":"Harris","year":"1991","journal-title":"Diabetes Care"},{"key":"10.3233\/JAD-160284_ref63","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","article-title":"Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160284_ref64","first-page":"109324","article-title":"Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro","volume":"2012","author":"Jiang","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160284_ref66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-122254","article-title":"Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: Beneficial effects of the LpPLA2 inhibitor darapladib","volume":"35","author":"Acharya","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref67","doi-asserted-by":"crossref","first-page":"e83094","DOI":"10.1371\/journal.pone.0083094","article-title":"Platelet aggregation unchanged by lipoprotein-associated phospholipase A(2) inhibition: Results from an in vitro study and two randomized phase I trials","volume":"9","author":"Shaddinger","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160284_ref68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jacc.2013.07.050","article-title":"Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging","volume":"63","author":"Tawakol","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.3233\/JAD-160284_ref69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trci.2015.06.003","article-title":"A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease","volume":"1","author":"Maher-Edwards","year":"2015","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-160284_ref70","doi-asserted-by":"crossref","first-page":"e88434","DOI":"10.1371\/journal.pone.0088434","article-title":"Effects of statins on incident dementia in patients with type 2 DM: A population-based retrospective cohort study in Taiwan","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160284_ref71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-160284_ref72","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160284_ref73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-141335","article-title":"Restoration of lipoxin A4 signaling reduces Alzheimer\u2019s disease-like pathology in the 3xTg-AD mouse model","volume":"43","author":"Dunn","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref74","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.ajpath.2013.01.051","article-title":"Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice","volume":"182","author":"Medeiros","year":"2013","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-160284_ref75","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3233\/JAD-159002","article-title":"Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"45","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160284_ref77","doi-asserted-by":"crossref","first-page":"e800","DOI":"10.1038\/tp.2016.65","article-title":"Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model","volume":"6","author":"Huttenrauch","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-160284_ref78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JAD-150352","article-title":"Exercise prevents amyloid-beta-induced hippocampal network disruption by inhibiting GSK3beta activation","volume":"52","author":"Isla","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160284_ref79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroimage.2015.09.050","article-title":"Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment","volume":"131","author":"Kobe","year":"2016","journal-title":"Neuroimage"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:44Z","timestamp":1777370624000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160284"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":79,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-160284","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}